Back to search

Article

High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates with Lower Survival

2021-10-08

Abstract excerpt

Glioblastoma (GBM), the most aggressive brain tumor, is associated with a median survival at diagnosis of 16-20 months and limited treatment options. The key hallmark of GBM is altered tumor metabolism and marked increase in the rate of glycolysis. Aerobic glycolysis along with elevated glucose consumption and lactate production supports rapid cell proliferation and GBM growth. In this study, we examined the gene...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d6a97b33-6e40-54aa-baf4-87e038fc11d8
DOI
10.1101/2021.10.07.463555
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
High Expression of Glycolytic Genes in Clinical Glioblastoma Patients Correlates with Lower SurvivalDOI 10.1101/2021.10.07.463555
Select a neighboring publication to make it the new centre.